Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Clinical trial NCT00142298 · COMPLETED

Trial details

NCT number: NCT00142298
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2005-03-01
Primary completion: 2009-11-01
Enrollment: 1869

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.